Adam Goldenberg, MD
Pain Medicine · Springfield, MANPI 1770018327
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,451 of the $3,938 with a category attached, or 62.2%. Abbott accounts for 63.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $2,706 and has fallen 93.5% since, to $177 in 2025.
Across 35 payments — averaging $112.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$619
- Boston Scientific$476
- Vertos Medical, Inc.$120
- Stryker$70
- E.r. Squibb & Sons, L.L.C.$47
- plus $114 from 4 others
What the payments were for
- Travel & lodging$2,45162%
- Food & beverage$1,35234%
- Education$1363%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $2,492 |
| Medtronic | 7 | $619 |
| Boston Scientific | 5 | $476 |
| Vertos Medical, Inc. | 1 | $120 |
| Stryker | 1 | $70 |
| E.r. Squibb & Sons, L.L.C. | 2 | $47 |
| AbbVie | 1 | $34 |
| SPR Therapeutics, Inc | 1 | $32 |
| Indivior Inc. | 1 | $31 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axium INS DRG IPG$1,173
- Proclaim IPG$789
- PROCLAIM$342
- GENERAL PAIN MANAGEMENT$259
- RESTORE$219
- INTELLIS$136
- mild Device Kit$120
- Superion Indirect Decompression System$101
How this compares
$3,938 in reported general payments places this provider in the 65th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 20 | $249 |
| Diazepam | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Springfield
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.